Open AccessS0820 Real World Comparison of Bio-Originator Infliximab vs the Biosimilar Infliximab-abda in the Treatment of Inflammatory Bowel Disease
Author(s) -
Ruthvik Padival,
Farah Heis,
Jeffrey A. Lee,
Farhan M. Qayyum,
Simon W. Lam,
Benjamin Click,
Miguel Regueiro,
Taha Qazi
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000705328.61690.cb
Subject(s) - infliximab , medicine , biosimilar , ulcerative colitis , inflammatory bowel disease , disease